Dermatology
ETAP-Lab has strong expertise in the field of dermatology research and has developed a wide portfolio of original in vivo models, and providing services to top tier Pharma, Nutrition and Medical device companies.
Neurology
ETAP-Lab provides original and translational models of Stroke and Alzheimer’s disease, through technology transfer from world-class academic teams in the field of neurology.
Health-nutrition
Etap-Lab has been testing innovative functional foods and ingredients for 30 years. The CRO has in-depth expertise in producing in vivo proof of the efficacy of naturally derived products having potential benefits.
About us
ETAP-Lab is an independent Contract Research Organization (CRO)
ETAP-Lab provides preclinical pharmacology and research services, as well as scientific expertise, to Pharmaceutical and Agro-Food industries. Our activity focuses on In Vivo models of pathologies and toxicology studies in rodents to support drug and nutraceutic R&D for our sponsors.
Since the foundation in 1991, ETAP-Lab’s Scientists have an in-depth expertise in pathology modeling with rodents. By respecting rodent chronobiology and natural behaviors, ETAP-Lab proposes research models with added translational value. All our models are customizable and original specific models can be set-up and validated on request.
Our News
-
Tau oligomer toxicity – our first data!
The new tau oligomers produced by ETAP-Lab show reproducible and dose-dependent toxicity on rodent primary neuron cultures. Promising and repeatedly replicated data show that tau oligomers exhibit dose-dependent toxicity that is
-
BIO Japan 2020
ETAP-Lab will be attending BIO-Japan 2020 as part of the Business France virtual French pavilion. We are delighted to have this unprecedented opportunity to reach out to the Japanese market. We
-
Let’s get back on track together!
Have your preclinical R&D projects fallen behind schedule during lockdown? Every industrial activity has been knocked sideways by the COVID-19 emergency - and healthcare R&D is no exception. Because we’ve been busy